Publications by authors named "Gary A Ulaner"

97Publications

18F-FDG PET/CT Helps Differentiate Peripheral Nerve Myeloid Sarcoma From a Presumed Benign Nerve Sheath Tumor.

Clin Nucl Med 2020 Dec;45(12):989-991

From the Department of Oncologic Imaging, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000003299DOI Listing
December 2020

Clinical utility of F-FDG PET/CT in staging and treatment planning of urachal adenocarcinoma.

J Nucl Med 2020 Sep 18. Epub 2020 Sep 18.

Memorial Sloan Kettering Cancer Center, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.120.251561DOI Listing
September 2020

Acute Aortic Dissection Initially Suspected on 18F-FDG PET/CT.

Clin Nucl Med 2020 Oct;45(10):819-820

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000003209DOI Listing
October 2020

Extramedullary Myeloma of the Uterus on 18F-FDG PET/CT: A Rare Manifestation of Multiple Myeloma.

Clin Nucl Med 2020 Nov;45(11):873-875

From the Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000003179DOI Listing
November 2020

Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted Zr-Pertuzumab PET/CT.

Radiology 2020 Aug 9;296(2):370-378. Epub 2020 Jun 9.

From the Department of Radiology (G.A.U., J.A.C., C.C.R., R.Y., V.H., B.M.Z., S.K.L., J.S.L.), Department of Pathology (D.S.R.), Department of Medicine (K.J., S.C., D.M.H.), and Molecular Pharmacology Program (B.M.Z., J.S.L.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 77, New York, NY 10065; Departments of Radiology (G.A.U., J.A.C., C.C.R., R.Y., V.H., S.K.L., J.S.L.) and Medicine (K.J., S.C., D.M.H.), Weill Cornell Medical College, New York, NY; and Department of Chemistry, Hunter College, City University of New York, New York, NY (B.M.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2020192828DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543717PMC
August 2020

CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging.

Radiology 2020 06 7;295(3):606-615. Epub 2020 Apr 7.

From the Department of Radiology (G.A.U., N.B.S., C.C.R., R.M., L.M.C., S.K.L., J.S.L.), Department of Medical Physics (J.A.O., A.S.K.), Myeloma Service, Department of Medicine (E.S., C.O.L.), and Molecular Pharmacology Program (J.S.L.), Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and Department of Radiology, Weill Cornell Medical College, New York, NY (G.A.U., C.C.R., J.S.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2020192621DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263286PMC
June 2020

Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders.

Best Pract Res Clin Haematol 2020 03 17;33(1):101148. Epub 2020 Jan 17.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA; Weill Cornell Medical College, New York, NY, 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2020.101148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410322PMC
March 2020

The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and Performance of Zr-DFO-Pertuzumab.

Theranostics 2020 1;10(4):1746-1757. Epub 2020 Jan 1.

Department of Chemistry, Hunter College, City University of New York, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/thno.39089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993239PMC
January 2020

The QIBA Profile for FDG PET/CT: Improving the Value of PET.

Authors:
Gary A Ulaner

Radiology 2020 Mar 7;294(3):658-659. Epub 2020 Jan 7.

From the Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 77, New York, NY 10065; and Department of Radiology, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2019192409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051153PMC
March 2020

Patient Repositioning Reveals a Malignant Pleura Effusion Initially Mistaken as a Bone Metastasis on 18FDG PET/CT.

Clin Nucl Med 2019 Dec;44(12):969-970

From the Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000002804DOI Listing
December 2019

Focal Immunotherapy-Induced Pancreatitis Mimicking Metastasis on FDG PET/CT.

Clin Nucl Med 2019 Oct;44(10):836-837

From the Department of Oncologic Imaging, Memorial Sloan Kettering Cancer Centre, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000002692DOI Listing
October 2019

PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?

Authors:
Gary A Ulaner

AJR Am J Roentgenol 2019 08 7;213(2):254-265. Epub 2019 May 7.

1 Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 77, New York, NY 10065.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.19.21177DOI Listing
August 2019

Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT.

Clin Nucl Med 2019 Apr;44(4):330-331

From the Department of Radiology, Memorial Sloan Kettering Cancer Center; and Department of Radiology, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000002467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687392PMC
April 2019

F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men.

J Nucl Med 2019 04 20;60(4):472-477. Epub 2018 Sep 20.

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.118.217836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448458PMC
April 2019

Uses and Opportunities for Molecular Imaging in Patients with Breast Cancer.

PET Clin 2018 07;13(3):xi-xii

Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA; Department of Radiology, Weill Cornell Medical School, New York, NY, 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2018.05.001DOI Listing
July 2018

Amino Acid Metabolism as a Target for Breast Cancer Imaging.

PET Clin 2018 Jul;13(3):437-444

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University Hospital, Room E152, 1364 Clifton Road, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2018.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092023PMC
July 2018

Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer.

PET Clin 2018 Jul;13(3):423-435

Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Department of Radiology, Weill Cornell Medical College, 1275 York Avenue, New York, NY 10065, USA; Program in Molecular Pharmacology and Chemistry, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Department of Pharmacology, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA; Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2018.02.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092024PMC
July 2018

Diagnostic Role of Fluorodeoxyglucose PET in Breast Cancer: A History to Current Application.

PET Clin 2018 Jul;13(3):355-361

Diagnostic Nuclear Medicine Division, Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, Delhi 110029, India. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2018.02.011DOI Listing
July 2018

Molecular Classification of Breast Cancer.

PET Clin 2018 Jul 7;13(3):325-338. Epub 2018 May 7.

Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2018.02.004DOI Listing
July 2018

Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.

J Clin Oncol 2018 08 10;36(24):2532-2537. Epub 2018 Jul 10.

Bob T. Li, Ronglai Shen, Darren Buonocore, Zachary T. Olah, Ai Ni, Michelle S. Ginsberg, Gary A. Ulaner, Michael Offin, Daniel Feldman, Helen H. Won, Edyta B. Brzostowski, Gregory J. Riely, David B. Solit, David M. Hyman, Alexander Drilon, Charles M. Rudin, Michael F. Berger, Jose Baselga, Maurizio Scaltriti, Maria E. Arcila, and Mark G. Kris, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY; Bob T. Li, Nick Pavlakis, and Stephen Clarke, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; and Todd Hembrough, Fabiola Cecchi, and Sarit Schwartz, NantOmics, Rockville, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.77.9777
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.77.9777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366814PMC
August 2018

Trends in oncologic hybrid imaging.

Eur J Hybrid Imaging 2018 19;2(1). Epub 2018 Jan 19.

1Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s41824-017-0019-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954767PMC
January 2018

89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.

Clin Nucl Med 2017 Dec;42(12):912-917

From the Departments of *Radiology and ‡Medicine, Memorial Sloan Kettering Cancer Center; Departments of †Radiology and §Medicine, Weill Cornell Medical College; and ∥Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001820DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708879PMC
December 2017

David Versus the Goliaths for the Detection of Bone Metastases.

Authors:
Gary A Ulaner

J Nucl Med 2017 11 17;58(11):1776-1777. Epub 2017 Aug 17.

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.117.199893DOI Listing
November 2017

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

Blood 2017 08 5;130(8):1007-1013. Epub 2017 Jul 5.

Service de Médecine Interne 2, Institut E3M, Centre de Références des Maladies Auto-Immunes et Systémiques Rares, Centre de Référence des Histiocytoses, Hôpital de la Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Pierre et Marie Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-01-761718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570678PMC
August 2017

Human Epidermal Growth Factor Receptor 2-Targeted PET/Single- Photon Emission Computed Tomography Imaging of Breast Cancer: Noninvasive Measurement of a Biomarker Integral to Tumor Treatment and Prognosis.

PET Clin 2017 Jul;12(3):269-288

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Program in Molecular Pharmacology and Chemistry, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2017.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545121PMC
July 2017

Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma.

Clin Orthop Relat Res 2017 Sep 23;475(9):2274-2279. Epub 2017 May 23.

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11999-017-5388-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539032PMC
September 2017

F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer.

Eur J Nucl Med Mol Imaging 2017 Aug 29;44(9):1420-1427. Epub 2017 Apr 29.

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3709-1DOI Listing
August 2017

Value of second-opinion review of outside institution PET-CT examinations.

Nucl Med Commun 2017 Apr;38(4):306-311

aDepartment of Radiology, Memorial Sloan Kettering Cancer Center bDepartment of Radiology, Weill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354085PMC
April 2017

Transient Osteoporosis of the Hip on FDG PET/CT.

Clin Nucl Med 2017 May;42(5):401-402

From the Department of Radiology, Memorial Sloan Kettering Cancer Center, New York; and Department of Radiology, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380528PMC
May 2017

FDG PET/CT Assesses the Risk of Femoral Pathological Fractures in Patients With Metastatic Breast Cancer.

Clin Nucl Med 2017 Apr;42(4):264-270

From the *Department of Radiology, Memorial Sloan Kettering Cancer Center, New York; †Department of Radiology, Weill Cornell Medical College, New York; ‡Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY; §Department of Orthopaedics, Cooper University Hospital, Camden, NJ; ∥Department of Surgery, Memorial Sloan Kettering Cancer Center, New York; and ¶Department of Surgery, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001580DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334437PMC
April 2017

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.

Clin Nucl Med 2016 Dec;41(12):995-997

From the Department of Radiology, Memorial Sloan Kettering Cancer Center; and Department of Radiology, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583704PMC
December 2016

Unilateral Suppression of Brown Fat on FDG PET/CT in Horner Syndrome.

Clin Nucl Med 2016 Oct;41(10):797-8

From the Departments of *Radiology and †Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001319DOI Listing
October 2016

Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients.

Am J Nucl Med Mol Imaging 2016 24;6(2):120-7. Epub 2016 Apr 24.

Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center 1275 York Avenue, NY 10065, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858608PMC
May 2016

Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.

Eur J Radiol 2016 Jun 31;85(6):1224-31. Epub 2016 Mar 31.

Section of Interventional Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2016.03.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675072PMC
June 2016

Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT.

J Nucl Med 2016 Oct 5;57(10):1523-1528. Epub 2016 May 5.

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York Department of Radiology, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050126PMC
http://dx.doi.org/10.2967/jnumed.115.172031DOI Listing
October 2016

(18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.

Eur J Nucl Med Mol Imaging 2016 Oct 30;43(11):1937-44. Epub 2016 Apr 30.

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-016-3402-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480318PMC
October 2016

The Impact That Number of Analyzed Metastatic Breast Cancer Lesions Has on Response Assessment by 18F-FDG PET/CT Using PERCIST.

J Nucl Med 2016 07 16;57(7):1102-4. Epub 2016 Mar 16.

Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.166629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493391PMC
July 2016

Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.

J Nucl Med 2016 Sep 3;57(9):1350-6. Epub 2016 Mar 3.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.170456DOI Listing
September 2016

Molecular Imaging of Biomarkers in Breast Cancer.

J Nucl Med 2016 Feb;57 Suppl 1:53S-9S

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York Department of Radiology, Weill Cornell Medical College, New York, New York; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.157909DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979972PMC
February 2016

Reply: Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?

J Nucl Med 2015 Aug 25;56(8):1293-4. Epub 2015 Jun 25.

Memorial Sloan Kettering Cancer Center 1275 York Ave., Box 77 New York, NY 10065 E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.161042DOI Listing
August 2015

Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma.

Radiology 2015 Nov 2;277(2):518-26. Epub 2015 Jun 2.

From the Departments of Radiology (G.A.U., J.L., H.S.), Epidemiology and Biostatistics (D.A.G., M.G.), and Medicine (C.S.S., J.M., C.H.M., A.D.Z.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and Departments of Radiology (G.A.U., H.S.) and Medicine (C.S.S., C.H.M., A.D.Z.), Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2015142556DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006668PMC
November 2015

Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma.

Blood 2015 Apr 10;125(16):2579-81. Epub 2015 Mar 10.

Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-10-606939DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624450PMC
April 2015

Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years.

J Nucl Med 2014 Oct 11;55(10):1578-83. Epub 2014 Sep 11.

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York Department of Radiology, Weill Cornell Medical College, New York, New York

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.114.143297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414239PMC
October 2014

Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?

AJR Am J Roentgenol 2014 Apr;202(4):859-67

1 Department of Radiology, Memorial Sloan-Kettering Cancer Center, 430 E 67th St, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.13.11239DOI Listing
April 2014

Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.

Cancer Med 2013 Oct 12;2(5):725-33. Epub 2013 Sep 12.

Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Radiology, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892804PMC
October 2013

False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.

J Clin Oncol 2014 Jan 18;32(1):51-6. Epub 2013 Nov 18.

All authors, Memorial Sloan-Kettering Cancer Center; and Gary A. Ulaner, Craig H. Moskowitz, and Andrew D. Zelenetz, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.50.8044
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.50.8044DOI Listing
January 2014

Identifying and distinguishing treatment effects and complications from malignancy at FDG PET/CT.

Radiographics 2013 Oct;33(6):1817-34

Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 77, New York, NY 10065, and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.336125105DOI Listing
October 2013

FDG-avid venous malformation could mimic malignancy on 18F-FDG PET/CT.

Clin Nucl Med 2013 Oct;38(10):826-8

From the *Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York; and †Department of Radiology, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e3182a20dd5DOI Listing
October 2013

Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT.

Clin Nucl Med 2013 Jun;38(6):480-1

Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e31828e98dcDOI Listing
June 2013

Focused regional FDG PET/CT detects more osseous metastases than does whole-body PET/CT.

Clin Nucl Med 2013 Mar;38(3):217-8

Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/nuclearmed/2013/03000/Focused_R
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/RLU.0b013e31827a27aeDOI Listing
March 2013

Hill-Sachs lesion on FDG PET/CT.

Clin Nucl Med 2013 Jan;38(1):65-6

Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e318270865cDOI Listing
January 2013

False-positive FDG PET/CT due to liver parenchymal injury caused by a surgical retractor.

Clin Nucl Med 2012 Sep;37(9):910-1

Department of Radiology, Memorial Sloan-Kettering Cancer Center; and †Weill Cornell Medical College, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e31825b23c0DOI Listing
September 2012

B-cell non-Hodgkin lymphoma: PET/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy--initial experience.

Radiology 2008 Mar 7;246(3):895-902. Epub 2008 Feb 7.

Department of Radiology, University of Southern California, 1200 N State St, GNH 3550, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2463060588DOI Listing
March 2008

An unsuspected MR projectile: a "wooden" chair with metal bracing.

J Magn Reson Imaging 2006 May;23(5):781-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.20573DOI Listing
May 2006

Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct.

J Nucl Med 2006 Feb;47(2):270-7

Department of Radiology and Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141555PMC
February 2006

IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.

Mol Hum Reprod 2005 Sep 11;11(9):631-40. Epub 2005 Oct 11.

Medical Service, VA Palo Alto Health Care System, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/molehr/gah230DOI Listing
September 2005

Telomere maintenance in clinical medicine.

Authors:
Gary A Ulaner

Am J Med 2004 Aug;117(4):262-9

Medical Service, VA Palo Alto Health Care System, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2004.02.048DOI Listing
August 2004

Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.

Genes Chromosomes Cancer 2004 Oct;41(2):155-62

Medical Service, VA Palo Alto Health Care System, and Department of Medicine, Stanford University, Palo Alto, California 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20074DOI Listing
October 2004

Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors.

Cancer Genet Cytogenet 2004 May;151(1):1-13

Medical Service, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2003.08.021DOI Listing
May 2004

Activating and silencing histone modifications form independent allelic switch regions in the imprinted Gnas gene.

Hum Mol Genet 2004 Apr 12;13(7):741-50. Epub 2004 Feb 12.

Medical Service, Veteran Affairs Palo Alta Health Care System and, Department of Medicine, Stanford University, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddh081DOI Listing
April 2004

Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.

J Cell Biochem 2003 Dec;90(5):1038-55

Medical Service, VA Palo Alto Health Care System, and Division of Endocrinology, Department of Medicine, Stanford University, Palo Alto, California 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.10684DOI Listing
December 2003

The histone code regulating expression of the imprinted mouse Igf2r gene.

Endocrinology 2003 Dec 15;144(12):5658-70. Epub 2003 Sep 15.

Medical Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2003-0798DOI Listing
December 2003

CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.

Endocrinology 2003 Oct 10;144(10):4420-6. Epub 2003 Jul 10.

Medical Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/endo/article-lookup/doi/10.1210/en.
Publisher Site
http://dx.doi.org/10.1210/en.2003-0681DOI Listing
October 2003

Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.

Cancer Res 2003 Apr;63(8):1759-63

Medical Service, Veterans Administration Palo Alto Health Care System, and Department of Medicine, Stanford University, Palo Alto, California 94304, USA.

View Article

Download full-text PDF

Source
April 2003